Amplification of the antitumor activity of phleomycins and bleomycins in rats and mice by caffeine.
While having no antitumor effect per se, caffeine substantially enhanced the antitumor effects of the phleomycins PLM-CHP and PLM-PEP, and the bleomycins BLM-CHP and Blenoxane in rats carrying Walker 256 carcinosarcoma and/or mice carrying Ehrlich ascites tumor, even at doses of phleomycin and bleomycin below the minimum effective level. Positive but less conclusive results were also obtained with PLM-A4A4G and PLM-G.
Allen
T E
TE
Aliano
N A
NA
Cowan
R J
RJ
Grigg
G W
GW
Hart
N K
NK
Lamberton
J A
JA
Lane
A
A
D000818:Animals; D001761:Bleomycin / Q000627:therapeutic use*; D002110:Caffeine / Q000494:pharmacology*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004247:DNA / Q000096:biosynthesis; D004260:DNA Repair / Q000187:drug effects; D004357:Drug Synergism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010692:Phleomycins / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D010692:Phleomycins; D001761:Bleomycin; D002110:Caffeine; D004247:DNA